ArticleCancer cell2016
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
Ilaria Marigo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it